Jürgen C. Becker

German Cancer Research Center — Germany

Medicine · Health Sciences

93h-index34.1kcitations863works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Polyomavirus and related diseases(212), Immunotherapy and Immune Responses(162), CAR-T cell therapy research(112), Antenna Design and Analysis(107), Full-Duplex Wireless Communications(96)

Publications861 total

Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition
Proceedings of the National Academy of Sciences·2025Open Access
EE509 Healthcare Resource Utilization (HCRU) and Associated Costs in Patients With Advanced Merkel Cell Carcinoma (aMCC) in Germany: Analysis From the MCC TRIM Registry Study
Value in Health·2025
71 Co-existing malignant subclones maintain a balance between Staphylococcus aureus-induced aggressiveness and intrinsic drug resistance in cutaneous T-cell lymphoma
Journal of Investigative Dermatology·2025
High-resolution spatial transcriptomics uncover epidermal-dermal divergences in Merkel cell carcinoma: spatial context reshapes the gene expression landscape
Oncogene·2025· 1 citedOpen Access
Data from Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer
2025Open Access
Supplementary Figures S1-S17 from Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer
2025· 1 citedOpen Access
Table S2 from Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer
2025Open Access
Table S1 from Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer
2025Open Access
Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response
Journal for ImmunoTherapy of Cancer·2025· 1 citedOpen Access
Leukemia cutis with concomitant acrodermatitis chronica atrophicans and chronic B‐cell lymphocytic leukemia: complete clearance under doxycycline therapy
JDDG Journal der Deutschen Dermatologischen Gesellschaft·2025Open Access
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients
European Journal of Cancer·2025· 1 citedOpen Access
IFN γ and the IFN γ Signaling Pathways in Merkel Cell Carcinoma
Cancers·2025Open Access
Deutsch‐Österreichische S2k‐Leitlinie: Anale Dysplasien und Analkarzinom‐Screening bei Menschen mit HIV
JDDG Journal der Deutschen Dermatologischen Gesellschaft·2025Open Access
Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
European Journal of Cancer·2025· 1 citedOpen Access
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial
British Journal of Dermatology·2025· 3 cited
Inhibitory Immune Checkpoints beyond Programmed Cell Death Ligand 1 in Merkel Cell Carcinoma: Abundant Expression of TIGIT Independent of the Presence of Merkel Cell Polyoma Virus
Acta Dermato Venereologica·2025Open Access
Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer
Cancer Discovery·2025· 2 citedOpen Access
Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis
Cancers·2025· 4 citedOpen Access
German‐Austrian guideline on screening for anal dysplasia and anal carcinoma in people living with HIV
JDDG Journal der Deutschen Dermatologischen Gesellschaft·2025· 5 citedOpen Access
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients
European Journal of Cancer·2025· 4 cited
page 1 of 44Next →

Frequent Co-authors

Dirk Schadendorf(12), David Schrama(8), Jochen Utikal(7), Selma Ugurel(7), Roland Houben(6), Carola Berking(6), Claus Garbe(5), Per thor Straten(5), Célèste Lebbé(5), Axel Hauschild(5), Antje Sucker(4), Patrick S. Moore(4), Alexander Enk(4), Sebastian Haferkamp(4), Joachim Klode(4), Narja Sahm(4), Jessica C. Hassel(3), Mark R. Middleton(3), Josep Malvehy(3), V. del Mármol(3)